Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
December 15, 2021
Tickers
GOVX
From Benzinga
Eli Lilly Shares Gain After Boosting 2021 Profit, Sales Forecast; Issues 2022 Guidance
December 15, 2021
Tickers
LLY
From Benzinga
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
From Benzinga
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
December 15, 2021
Tickers
OCGN
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
From Benzinga
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection
December 14, 2021
From Benzinga
Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: Reuters
December 14, 2021
Tickers
NVAX
From Benzinga
Moderna, Australia Collaborate To Bring mRNA Manufacturing To Australia
December 14, 2021
Tickers
MRNA
From Benzinga
Samsung Biologics, AstraZeneca Expand Collaboration To Include COVID-19, Cancer Therapy
December 14, 2021
From Benzinga
Final Data Reaffirms Efficacy Of Pfizer's COVID-19 Antiviral Treatment
December 14, 2021
Tickers
PFE
From Benzinga
Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing
December 10, 2021
Tickers
APDN
From Benzinga
FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & Older
December 09, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised
December 09, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows
December 08, 2021
From Benzinga
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
December 07, 2021
From Benzinga
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
December 07, 2021
From Benzinga
Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ
December 07, 2021
From Benzinga
FDA Enlists Thermo Fisher, Google-Backed Verily COVID-19 Tests Likely To Be Affected By Omicron
December 07, 2021
From Benzinga
Anixa Biosciences Says COVID-19 Compounds Potentially Effective Against Omicron Variant
December 07, 2021
Tickers
ANIX
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
From Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
December 07, 2021
From Benzinga
From Benzinga
RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations
December 06, 2021
Tickers
RDHL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
